cagrisema vs retatrutide ADA 2026 Obesity Drug Updates: Retatrutide, CagriSema, and Oral GLP-1s IMPORTANT: Next GLP-1 Coming! RETATRUTIDE

Contains: Milk & Soy (used in fermentation media) SUGGESTED USE: Take one capsule daily 30 minutes prior to a meal.

Gut Microbes 7 (3), 189200

Bimagrumab, a monoclonal antibody targeting ActRIIA/IIB, inhibits myostatin and activins, promoting muscle hypertrophy and reducing fat mass

Currently, no existing guidelines provide definitive directions on this clinical issue

Studying GLP-1, GIP, and glucagon triple RA for the treatment of MASLD/MASH follows the success of mono- and dual-agonists helping patients with type 2 diabetes and obesity achieve clinical targets by offering advantages of each constitutive component while minimising the risk of undesirable effects